Where I see patients (3)
Selected research
-
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.
JBMR plus
-
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level.
The Journal of clinical endocrinology and metabolism
-
Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia.
The Journal of clinical endocrinology and metabolism
Contact me
Learning never stops
Our classroom and bedside classes help kids get credit and keep learning during treatment.
See our school program![](/-/media/project/ucsf/ucsf-bch/images/by-your-side-moment/owl/bys_footer_owl-playful-2x.jpg?rev=867a00ac8b5641a69c9247247e61be9d&hash=A71A2CCC5ECF3E80435E557132E60C39)